iCAD

$5.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-3.08%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell iCAD and other stocks, options, ETFs, and crypto commission-free!

About ICAD

iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy business segments. Read More The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. The company was founded in 1984 and is headquartered in Nashua, NH.

Employees
97
Headquarters
Nashua, New Hampshire
Founded
1984
Market Cap
115.19M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
72.66K
High Today
$6.19
Low Today
$5.93
Open Price
$6.16
Volume
111.55K
52 Week High
$7.45
52 Week Low
$2.43

Collections

ICAD News

ReutersAug 21

Edited Transcript of ICAD earnings conference call or presentation 1-Aug-19 12:30pm GMT

0

ICAD Earnings

-$0.19
-$0.15
-$0.10
-$0.06
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market

More ICAD News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.